Bone Void Filler
-
Biologics
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
ALLENDALE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a…
Read More » -
Financial
The Global Bone Void Fillers Market size is expected to reach $6.1 billion by 2030, rising at a market growth of 7.9% CAGR during the forecast period
The main factor contributing to the rise of bone fracture, particularly in children, is a particular sport’s year-round participation. Bone…
Read More » -
Biologics
Abyrx Receives Additional FDA Clearances for MONTAGE® Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement
STAMFORD, Conn., April 5, 2023 /PRNewswire/ — Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for…
Read More » -
Spine
NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty
Attrax Putty is now on-label for use with cervical Modulus interbody implants SAN DIEGO, Feb. 21, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the…
Read More » -
Biologics
curasan AG broadens orthobiologic portfolio with the launch of CERASORB® CPC (Calcium Phosphate Cement) bone void fillers.
Frankfurt, Germany, July 25, 2022 /OrthoSpineNews/ – curasan AG (Frankfurt, Germany), a pioneer and leading global provider of biomaterials for…
Read More » -
Biologics
Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications
Colleyville, TX, July 13, 2022 /OrthoSpineNews/— Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has…
Read More » -
Financial
Global Bone Void Fillers Market estimated at $3.5 billion (2022), is growing at a CAGR of 6%
Medi-Tech Insights: The global bone void fillers market growth is driven by growing orthopaedic disorders and technological advancements. BRUSSELS, Belgium,…
Read More » -
Spine
Bone Solutions Inc. Receives FDA Clearance for Mg OSTEOREVIVE Spine Magnesium-Based Bone Void Filler
Colleyville, TX (February 2, 2022) / OrthoSpineNews / — Bone Solutions Inc. (BSI), a orthobiologics technology company located in Colleyville,…
Read More » -
Biologics
Bone Solutions Launches Mg OSTEOINJECT Injectable Magnesium-Based Bone Void Filler
Colleyville, TX, January 25, 2022 / OrthoSpineNews / — Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville,…
Read More » -
Hospitals
HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler
SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ — Following Elute, Inc.’s Investigational Device Exemption (IDE) authorization from the US Food and Drug Administration (FDA)…
Read More » -
Biologics
Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures
September 21, 2021 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More »